Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis (Q58971133)
Jump to navigation
Jump to search
article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis |
article |
Statements
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis (English)
Artur Racewicz
Christian Roux
Claude-Laurent Benhamou
Zulema Man
Ellen Matzkin
Steven Boonen
Pierre D Delmas
José R Zanchetta
Rachelle A Eusebio
John F Beary
David E Burgio
8 September 2007